Recombinant Mouse Interferon gamma  is produced by our Mammalian expression system and the target gene encoding His23-Cys155 is expressed.

【本資料源自公開渠道，如需（此處）屏蔽，請聯(lián)系刪除】

標(biāo)題:Reprogrammed IDO-Induced Immunosuppressive Microenvironment Synergizes with Immunogenic Magnetothermodynamics for Improved Cancer Therapy

成員:Xun Wang, Bin Yan, Hugang Li, Jianlan Yuan, Jingyi Guo, Siyao Wang, Penggao Dai, Xiaoli Liu

論文因子:8.3 發(fā)表期刊:ACS Applied Materials & Interfaces pmid:38843203

【本資料源自公開渠道，如需（此處）屏蔽，請聯(lián)系刪除】

標(biāo)題:Qingfei mixture mitigates immunosuppression of tumor microenvironment in non-small cell lung cancer by blocking stat1/Ido1-mediated tryptophan-kynurenine pathway

成員:Zhuo Chen, Yu-Heng Ding, Lan Shao, Xu-Ming Ji, Xiang Qian, Ai-Qin Zhang

論文因子:4 發(fā)表期刊:Heliyon pmid:38882349

【本資料源自公開渠道，如需（此處）屏蔽，請聯(lián)系刪除】

標(biāo)題:Thiamine pretreatment improves endotoxemia-related liver injury and cholestatic complications by regulating galactose metabolism and inhibiting macrophage activation

成員:Tongxi Li, Junjie Bai, Yichao Du, Peng Tan, Tianxiang Zheng, Yifan Chen, Yonglang Cheng, Tianying Cai, Meizhou Huang, Wenguang Fu, Jian Wen

論文因子:5.714 發(fā)表期刊:INTERNATIONAL IMMUNOPHARMACOLOGY pmid:35640376

【本資料源自公開渠道，如需（此處）屏蔽，請聯(lián)系刪除】

標(biāo)題:Inflammation responsive tofacitinib loaded albumin nanomedicine for targeted synergistic therapy in ulcerative colitis

成員:Li Bang, Liu Xiaoyan, Long Qi, Zhuang Xiaoduan, Gao Yanfei, Ali Barkat, Chen Haoting, Zhang Dongyang, Wang Xinying, Guo Weisheng

論文因子:9.9 發(fā)表期刊:Nano Research

【本資料源自公開渠道，如需（此處）屏蔽，請聯(lián)系刪除】

標(biāo)題:Inflammation responsive tofacitinib loaded albumin nanomedicine for targeted synergistic therapy in ulcerative colitis

成員:Li Bang, Liu Xiaoyan, Long Qi, Zhuang Xiaoduan, Gao Yanfei, Ali Barkat, Chen Haoting, Zhang Dongyang, Wang Xinying, Guo Weisheng

論文因子:9.9 發(fā)表期刊:Nano Research

注意：以上文獻(xiàn) 僅供參考

RecombinantMouseInterferonγ/IFN-γ/IFNg

RecombinantMouseInterferonγ/IFN-γ/IFNg